Patients Rush to ER as Asthma Drug Discontinued – Urgent NPR Report

TL/DR –

The discontinuation of Primatene Mist, an over-the-counter inhaler used for temporary relief of mild symptoms of intermittent asthma, has left some patients scrambling for alternatives and others in the emergency room. The inhaler’s manufacturer, Amphastar Pharmaceuticals, cited a lack of raw materials as the reason for the discontinuation. While it was not a long-term management solution for asthma, many patients relied on it for immediate relief, and experts fear that without access to affordable alternatives, these patients might risk going without treatment.

Asthma Patients Struggle in Wake of Discontinued Medication

Patients suffering from asthma are in a state of distress due to the discontinuation of a popular asthma medication. This has caused a scramble for alternatives, with some patients even being forced to seek emergency treatment. Find out more here.

The Impact of Discontinued Asthma Medication on Patients

Asthma patients across the country are feeling the impact of the asthma medication discontinuation. Many are struggling to find a replacement therapy, and the increased demand is causing shortages at pharmacies. Some patients have experienced asthma attacks requiring emergency treatment as a result.

Seeking Asthma Medication Alternatives

Asthmatics are now seeking alternative medications and treatments in the wake of the discontinuation. Health experts are urging patients to consult with their healthcare providers to discuss suitable alternatives. They stress the importance of personalized treatment plans considering the varying severity and triggers of asthma among patients.

—
Read More Health & Wellness News ; US News